OREANDA-NEWS. According to the results for the first 9 months of 2013 total sales of the top five best selling Rx drugs amounted to RUR 1,145.2 million, which corresponds to 43.8% of sales in the Rx drugs segment and 31.8%[1] of the Company's total sales.

According to the results of the first 9 months of 2013 the top five best selling Rx drugs are:

Geptor (Ademetionine; ATC[2] "Digestive tract and metabolism"); sales increased by 31.2% as compared to the same period of the previous year; 14.4% of sales in the Rx drugs segment;

Tautax (Docetaxel; ATC "Antineoplastic and immunomodulating agents"); sales in the segment made 10.1%;

Cerepro (Choline Alfoscerate; ATC "Medications for the treatment of the nervous system deseases"); sales in the segment made 8.6%;

Irunine (Itraconazole; ATC "Antimicrobials for systematic use"); sales in the segment made 6.0%;

Parclitaxel-LENS (Parclitaxel; ATC "Antineoplastic and immunomodulating agents"); sales in the segment made 4.7%;

OTC drugs

OTC drugs segment is characterized by the high degree of consolidation. It means that the top five best selling medicines make 98.4% of sales.

Xilen (Xylometazoline; ATC "Medications for the treatment of respiratory system"); sales in the OTC drugs segment made 45.0%;

Slabilen (Sodium picosulfate; ATC "Alimentary tract and metabolism"); sales in the OTC drugs segment made 33.2%;

Motilak (Domperidone; ATC "Alimentary tract and metabolism"); sales in the OTC drugs segment made 16.2%;

Vitasharm and Vitatress (ATC "Vitamins"); sales in the OTC drugs segment made 3.2%;

Ginkgo biloba (Ginkgo biloba; ATC "Medications for the treatment of urogenital organs"); sales in the OTC drugs segment made 0.8%.

Traditional drugs segment

According to the results of 9 months of 2013 the top five best selling prescription medications are:

Vero-Dexamethasone (Dexamethasone; ATC "Hormonal drugs for systematic use"); sales in the traditional drugs segment made 42.1%;

Pyridoxine (ATC "Alimentary tract and metabolism"); sales in the segment made 22.1%;

Vero-Ciprofloxacin (Ciprofloxacin; ATC "Antimicrobials for systematic use"); sales in the segment made 12.9%;

Vero-Loperamide (Loperamide; ATC "Alimentary tract and metabolism"); sales in the segment made 12.7%;

Vero-Flukonazole (Fluconazole; ATC "Antimicrobials for systematic use"); sales in the segment made 5.4%;

Non-pharamaceutical products

According to the results of 9 months of 2013 the top five best selling non-pharamaceutical products are:

Conventional antimicrobial adhesive bandages; 35.7% of sales in the segment;

Conventional reel adhesive bandages; 24.5% of sales in the segment;

Therapeutic patches - pepper plasters; 18.2% of sales in the segment;

Therapeutic patches - corn plasters; 14.4% of sales in the segment;

Condoms; 4.0% of sales in the segment.

NEW DRUGS PRODUCTION AND SALES

During 9 months of 2013 Veropharm launched production and sales of the following new drugs:

Anfibra (Enoxaparin sodium; ATC "Medications affecting hematogenesis and blood");

Salbutamol (Salbutamol; ATC "Medications for the treatment of respiratory system");

ACP (Escitolapram, ATC "Medications for the treatment of the nervous system deseases");

Gistamel (Imatinib; ATC " Antineoplastic and immunomodulating agents");

Bereta (Rabeprazole; ATC "Alimentary tract and metabolism")

For 9 months of 2013 Veropharm has initiated the sales of condoms under its own brand name:

"Sensex" (Condoms; ATC "Medical items").

NEW DRUGS REGISTRATION

During 9 months of 2013 Veropharm received registration for the following 2 drugs:

ACP (Escitolapram, ATC "Medications for the treatment of the nervous system deseases");

Gistamel (Imatinib; ATC " Antineoplastic and immunomodulating agents")

And the the following non-medical products:

Detoksiver - dietary supplement;

8 dietary products for weight control “Nutrico Diet®”;

9 perfume and cosmetic products.

At present 41 products are in the development plan and 23 drugs are currently at different stages of the registration process.

[1] % - percent of finished goods sales

[2] ATC - anatomico-therapeutico-chemical group